EVP, Chief Dev. Officer of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Frenkel Ran, sells 2,887 shares worth $42,818
According to Karyopharm Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:11 PM, company EVP, Chief Dev. Officer, Frenkel Ran disclosed selling 2,887 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $42,818 in total. As of Feb 18, Frenkel Ran now owns 46,126 shares in total worth about $688,199.92.
For the last few recent trades made by Karyopharm Therapeutics Inc. (NASDAQ:KPTI) EVP, Chief Dev. Officer, Frenkel Ran, we have the following information:
- SEC Form 4 filing: Feb 11: Sold 2,046 shares at the rate of $15.52 per share. Total worth of this trade was $31,752. Total number of shares owned as of Feb 11 were 39,338
- SEC Form 4 filing: May 07: Sold 1,974 shares at the rate of $20.00 per share. Total worth of this trade was $39,480. Total number of shares owned as of May 07 were 35,088
- SEC Form 4 filing: Feb 19: Sold 2,975 shares at the rate of $16.48 per share. Total worth of this trade was $49,034. Total number of shares owned as of Feb 19 were 36,066
Posted by
George Daniels
on Tuesday February 23 2021, 12:02 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
